spacer
home > ict > autumn 2017 > teaming up
PUBLICATIONS
International Clinical Trials

Teaming Up

ICT: Your event claims it will provide discussions
regarding partnerships. What do these entail?


Louisa Maitland: Partnerships in Clinical Trials (PCT)
brings together groups of experts who are involved in
setting up, running and delivering trials; it is a meeting
place to discuss strategy, business and innovation.
Historically, PCT has mainly centred on the relationship
between the pharmaceutical or biotechnology company
and the CRO, but as the event has evolved over the
years, the focus has shifted. Today, a true partnership
will involve successful collaborations between sponsors,
CROs, regulators, investigators and, most importantly, the
patient. Communication and understanding of business
necessities are needed between all relevant parties, as
well as increasing operational efficiencies, streamlining
the development process, expanding global reach and
complementing internal knowledge with external expertise.

Throughout the industry, pharma and biotech
manufacturers, patient groups and policy makers are
continuing the mission to enhance collaborations with
subjects to align stakeholder needs and

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Louisa Maitland is Conference Director of PCT Europe, developing the event in partnership with the advisory board.
She completed an MSc at Kings College, UK, in forensic science and a BSc at Reading University, UK, in environmental science. After experience as both a Forensic Toxicologist and a Biochemist, for the last 16 years Louisa has worked in conference production, researching key trends and current challenges within various industry sectors, such as pharma, biotech and, most recently, clinical trials.
spacer
Louisa Maitland
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Productive Networking Of Pharmaceutical Leaders At PHARMAP 2022

Connecting innovators in the pharmaceutical industry and contributing to further development of ongoing pharmaceutical trends were the main directions of PHARMAP 2022. The Congress gathered pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies to exchange experience in digital transformation and discuss innovative solutions and business practices. The Congress was held on June, 20-21, 2022 in Berlin, Germany.
More info >>

White Papers

Migration safe pharmaceutical labels improve patient safety

UPM Raflatac

Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement